These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27824899)

  • 1. Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer.
    Heger Z; Merlos Rodrigo MA; Michalek P; Polanska H; Masarik M; Vit V; Plevova M; Pacik D; Eckschlager T; Stiborova M; Adam V
    PLoS One; 2016; 11(11):e0165830. PubMed ID: 27824899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of sarcosine metabolism in prostate cancer progression.
    Khan AP; Rajendiran TM; Ateeq B; Asangani IA; Athanikar JN; Yocum AK; Mehra R; Siddiqui J; Palapattu G; Wei JT; Michailidis G; Sreekumar A; Chinnaiyan AM
    Neoplasia; 2013 May; 15(5):491-501. PubMed ID: 23633921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
    Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
    Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
    Sreekumar A; Poisson LM; Rajendiran TM; Khan AP; Cao Q; Yu J; Laxman B; Mehra R; Lonigro RJ; Li Y; Nyati MK; Ahsan A; Kalyana-Sundaram S; Han B; Cao X; Byun J; Omenn GS; Ghosh D; Pennathur S; Alexander DC; Berger A; Shuster JR; Wei JT; Varambally S; Beecher C; Chinnaiyan AM
    Nature; 2009 Feb; 457(7231):910-4. PubMed ID: 19212411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcosine influences apoptosis and growth of prostate cells via cell-type specific regulation of distinct sets of genes.
    Rodrigo MAM; Strmiska V; Horackova E; Buchtelova H; Michalek P; Stiborova M; Eckschlager T; Adam V; Heger Z
    Prostate; 2018 Feb; 78(2):104-112. PubMed ID: 29105933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brucine Suppresses Malignant Progression of Prostate Cancer by Decreasing Sarcosine Accumulation via Downregulation of GNMT in the Glycine/sarcosine Metabolic Pathway.
    Miao L; Liu Y; Chen W; Gao C; Zhang Y; Wei J; Cao X
    Cell Biochem Biophys; 2024 Sep; 82(3):2373-2385. PubMed ID: 38877335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the metabolome suggests a major potential role of sarcosine in the progression of cancer of the prostate].
    Darbon JM
    Bull Cancer; 2009 Apr; 96(4):355-6. PubMed ID: 19562840
    [No Abstract]   [Full Text] [Related]  

  • 8. NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation.
    Nadiminty N; Chun JY; Lou W; Lin X; Gao AC
    Prostate; 2008 Dec; 68(16):1725-33. PubMed ID: 18781579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcosine is a prostate epigenetic modifier that elicits aberrant methylation patterns through the SAMe-Dnmts axis.
    Strmiska V; Michalek P; Lackova Z; Guran R; Krizkova S; Vanickova L; Zitka O; Stiborova M; Eckschlager T; Klejdus B; Pacik D; Tvrdikova E; Keil C; Haase H; Adam V; Heger Z
    Mol Oncol; 2019 May; 13(5):1002-1017. PubMed ID: 30628163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Evaluation of
    Piert M; Shao X; Raffel D; Davenport MS; Montgomery J; Kunju LP; Hockley BG; Siddiqui J; Scott PJH; Chinnaiyan AM; Rajendiran T
    J Nucl Med; 2017 Aug; 58(8):1216-1223. PubMed ID: 28302759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth.
    Bindukumar B; Schwartz SA; Nair MP; Aalinkeel R; Kawinski E; Chadha KC
    Neoplasia; 2005 Mar; 7(3):241-52. PubMed ID: 15799824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
    Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.
    Jennbacken K; Gustavsson H; Tesan T; Horn M; Vallbo C; Welén K; Damber JE
    Prostate; 2009 Aug; 69(11):1164-75. PubMed ID: 19399749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.
    Cao P; Deng Z; Wan M; Huang W; Cramer SD; Xu J; Lei M; Sui G
    Mol Cancer; 2010 May; 9():108. PubMed ID: 20478051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
    Cha YJ; Kim DH; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(11):7824-33. PubMed ID: 25550822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analysis of differentially expressed genes and pathways associated with mitoxantrone treatment prostate cancer.
    Li S; Li R; Ma Y; Zhang C; Huang T; Zhu S
    J Cell Mol Med; 2019 Mar; 23(3):1987-2000. PubMed ID: 30592148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells.
    Moretti RM; Marelli MM; Motta M; Polizzi D; Monestiroli S; Pratesi G; Limonta P
    Prostate; 2001 Mar; 46(4):327-35. PubMed ID: 11241556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
    Green T; Chen X; Ryan S; Asch AS; Ruiz-Echevarría MJ
    Prostate; 2013 Oct; 73(14):1561-75. PubMed ID: 23824605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.